J&J agrees to Propulsid settlement
Executive Summary
A Johnson & Johnson Propulsid litigation settlement will become effective once 85% of the death claims agree to its terms, J&J's Janssen division announced Feb. 5. J&J will pay between $69.5 mil. and $90 mil., depending on how many plaintiffs enroll in the program. The federal multi-district litigation includes approximately 4,000 plaintiffs, 300 of whom are alleged to have died from use of the drug. J&J ceased marketing Propulsid (cisapride) in 2000; the gastrointestinal agent is currently available through a limited access program...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.